688 related articles for article (PubMed ID: 2125699)
1. Purine metabolism enzymes and immunological phenotype in chronic B-cell malignancies: chronic lymphocytic leukemia, prolymphocytic leukemia and hairy cell leukemia.
Babusíková O; Hrivnáková A; Klobusická M; Mesárosová A; Ujházy P
Neoplasma; 1990; 37(6):693-701. PubMed ID: 2125699
[TBL] [Abstract][Full Text] [Related]
2. Purine metabolism enzyme pattern, cytochemical characteristics and clinicopathologic features of CD10-positive childhood T-cell leukemia.
Babusíková O; Cáp J; Hrivnáková A; Klobusická M; Mesárosová A; Koníková E
Neoplasma; 1991; 38(6):595-602. PubMed ID: 1837333
[TBL] [Abstract][Full Text] [Related]
3. Enzymatic differences between chronic lymphocytic leukemia and prolymphocytic leukemia.
Ratech H; Borer WZ; Winberg CD; Rappaport H
Leuk Res; 1985; 9(10):1271-5. PubMed ID: 3934467
[TBL] [Abstract][Full Text] [Related]
4. Diagnosis and analysis of the clinical course of T-phenotype acute lymphoblastic leukemia.
Babusíková O; Hrivnáková A; Cáp J; Ujházy P
Neoplasma; 1988; 35(6):683-90. PubMed ID: 2975765
[TBL] [Abstract][Full Text] [Related]
5. Enzymes of purine metabolism and membrane phenotype in malignant cells of some leukemia patients.
Babusíková O; Hrivnáková A; Pechán I; Ujházy P
Neoplasma; 1984; 31(6):661-6. PubMed ID: 6441124
[TBL] [Abstract][Full Text] [Related]
6. [Alpha-L-fucosidase of normal and pathological blood cells].
Percheron F; Bernard M; Foglietti MJ
Bull Acad Natl Med; 1991 Feb; 175(2):205-14; discussion 215. PubMed ID: 1863862
[TBL] [Abstract][Full Text] [Related]
7. [Chronic lymphocytic leukemia. II. Differentiation of various forms of chronic lymphocytic leukemia by cytological and immunological indicators].
Popova L; Apostolov P; Vlaĭkova S; Stamenova L
Vutr Boles; 1988; 27(3):76-80. PubMed ID: 3264645
[TBL] [Abstract][Full Text] [Related]
8. Monoclonal antibody studies in B(non-T)-cell malignancies.
Shimoyama M; Minato K; Tobinai K; Nagai M; Hirose M
Jpn J Clin Oncol; 1983 Sep; 13(3):477-88. PubMed ID: 6417373
[TBL] [Abstract][Full Text] [Related]
9. Immune phenotype and some enzyme patterns in phorbol ester-induced chronic lymphocytic leukemia cells.
Babusíková O; Mesárosová A; Kusenda J; Koníková E; Klobusická M; Hrivnáková A
Neoplasma; 1995; 42(5):221-6. PubMed ID: 8552199
[TBL] [Abstract][Full Text] [Related]
10. Blastic transformation of hairy cell leukemia.
Nazeer T; Burkart P; Dunn H; Jennings TA; Wolf B
Arch Pathol Lab Med; 1997 Jul; 121(7):707-13. PubMed ID: 9240906
[TBL] [Abstract][Full Text] [Related]
11. [The prolymphocytic-lymphocytic leukemization of B-cell lymphosarcomas].
Osmanov DSh; Kruglova GV; Frenkel' MA; Tupitsin NN; Probatova NA; Kondrat'eva TT; Sholokhova EN; Finogenova IA; Dvoretskiĭ VV
Ter Arkh; 1996; 68(7):42-8. PubMed ID: 8928071
[TBL] [Abstract][Full Text] [Related]
12. The diagnostic value of CD123 in B-cell disorders with hairy or villous lymphocytes.
Del Giudice I; Matutes E; Morilla R; Morilla A; Owusu-Ankomah K; Rafiq F; A'Hern R; Delgado J; Bazerbashi MB; Catovsky D
Haematologica; 2004 Mar; 89(3):303-8. PubMed ID: 15020268
[TBL] [Abstract][Full Text] [Related]
13. [Chronic lymphatic leukemia. Immunophenotyping as an aid to correct diagnosis].
Ly B; Hammerstrøm J; Bergheim J; Dahl IM; Grøttum KA; Lødemel B; Baklien K; Smeland E
Tidsskr Nor Laegeforen; 1998 Jan; 118(2):233-7. PubMed ID: 9485618
[TBL] [Abstract][Full Text] [Related]
14. Induction of features characteristic of hairy cell leukemia in chronic lymphocytic leukemia and prolymphocytic leukemia cells.
Ziegler-Heitbrock HW; Munker R; Dörken B; Gaedicke G; Thiel E
Cancer Res; 1986 Apr; 46(4 Pt 2):2172-8. PubMed ID: 3456270
[TBL] [Abstract][Full Text] [Related]
15. [Expression of proliferation marker Ki 67 in chronic lymphocytic leukemia].
Diop S; Letestu R; Orsolani D; Leboeuf Y; Le Tutour P; Thiam D; Diakhate L; Valensi F
Dakar Med; 2005; 50(2):65-8. PubMed ID: 16295759
[TBL] [Abstract][Full Text] [Related]
16. Flow cytometry of peripheral blood and bone marrow cells from patients with hairy cell leukemia: phenotype of hairy cells, lymphocyte subsets and detection of minimal residual disease after treatment.
Babuŝíková O; Tomová A; Kusenda J; Gyárfás J
Neoplasma; 2001; 48(5):350-7. PubMed ID: 11845978
[TBL] [Abstract][Full Text] [Related]
17. CD5+ chronic B-cell leukemia with features intermediate to chronic lymphocytic leukemia and hairy cell leukemia.
Aljurf M; Cornbleet PJ; Michel F
Hematol Pathol; 1994; 8(3):99-109. PubMed ID: 7527021
[TBL] [Abstract][Full Text] [Related]
18. Immunocytochemical detection of kappa and lambda light chain V region subgroups in human B-cell malignancies.
Solomon A; Weiss DT; Macy SD; Antonucci RA
Am J Pathol; 1990 Oct; 137(4):855-62. PubMed ID: 2121042
[TBL] [Abstract][Full Text] [Related]
19. A comparison of some leucocyte differentiation markers and the adenosine deaminase and purine nucleoside phosphorylase values in B and T cell leukemias and lymphomas.
Mesárosová A; Hrivnáková A; Babusíková O
Neoplasma; 1995; 42(6):307-12. PubMed ID: 8592572
[TBL] [Abstract][Full Text] [Related]
20. B7 costimulatory molecules from malignant cells in patients with b-cell chronic lymphoproliferative disorders trigger t-cell proliferation.
Trentin L; Perin A; Siviero M; Piazza F; Facco M; Gurrieri C; Galvan S; Adami F; Agostini C; Pizzolo G; Zambello R; Semenzato G
Cancer; 2000 Sep; 89(6):1259-68. PubMed ID: 11002221
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
